Sequans Receives Notice of Non-Compliance with NYSE Trading Share Price and Market Capitalization Listing Rules
Under the NYSE standards, the Company has six months following receipt of the notification to regain compliance with the minimum share price requirement.
- Under the NYSE standards, the Company has six months following receipt of the notification to regain compliance with the minimum share price requirement.
- The Company intends to cure the price deficiency and return to compliance with the NYSE continued listing requirement within the applicable cure period.
- Sequans is currently evaluating its available options and developing a plan to regain compliance with the minimum global market capitalization requirement.
- The Company's ADSs will continue to be listed and trade on the NYSE during the Cure Periods, subject to the Company's compliance with other NYSE continued listing standards.